Autopsy report · NCT02621853

Clinical Validation of a Raman Spectroscope to Determine Hepatic Fat Content

“Principal Investigator is also study sponsor. Dr. Alwayn is leaving NSHA and Canada for a new appointment in Europe.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 3 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Nova Scotia Health Authority

Sponsor type

University, hospital or other

Conditions

Steatosis

Interventions

Raman spectroscopy of the liver

Participants

3

Trials that died the same way

• Surgical Field Bacterial Contamination in Primary Total Hip (THA) and Knee (TKA) Arthroplasty
  “Study principal investigator left the organization” (60% match in meaning)
• Wearable Auscultation Device Validation in Children
  “The Principal Investigator is departing from the study site.” (59% match in meaning)
• Single-portal Endoscopic Carpal Tunnel Release Versus Knifelight for Carpal Tunnel Syndrome. A Randomized Control Trial
  “The principal investigator of the study relocated to another institution.” (58% match in meaning)
• Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa)
  “Departure of the Principal Investigator” (58% match in meaning)
• "Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.
  “Principal Investigator's departure” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.